TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
RAPP

Rapport Therapeutics, Inc.

Healthcare · Biotechnology

42.00$ +1.4% vs. previous close Closing price · As of: Sep 17, 2026

Investor relations

Report Dates

Investor relations overview for Rapport Therapeutics, Inc. (RAPP): report dates, earnings surprises, earnings call transcripts and the latest headlines. The next report is scheduled for 11/05/2026.

Next report 11/05/2026
Last report 08/05/2026
Earnings surprise by quarter (%)
Q2 24 · -150.0 % 24 Q3 24 · 3.9 % 24 Q4 24 · 18.6 % 24 Q1 25 · 8.1 % 25 Q2 25 · 13.8 % 25 Q3 25 · 2.7 % 25 Q4 25 · -6.8 % 25 Q1 26 · 40.9 % 26 Q2 26 · -28.0 % 26

EPS estimate beaten

Full history 6 of 10 quarters (60%)

Earnings Call Transcripts

Search all transcripts →

No transcripts yet — they will show up here automatically after the next earnings call.

News on This Stock

  • 08/05/2026 Rapport Therapeutics, Inc. (RAPP): Results of Operations and Financial Condition; Financial Statements and Exhibits · sec.gov Open ↗

Automatically matched wire and portal stories; external links open the original source.

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Transcripts: transcript archive

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?